‹ Story
Concise.
 ScienceDaily article provenance

NOACs slow cognitive decline in Alzheimer’s patients with atrial fibrillation

They publishedThese blood thinners may have an unexpected benefit for Alzheimer’s patients
Who / What / Where / When
Who
ScienceDaily — 🇺🇸 United States
credibility ●●●○○ 3/5 curated · lean center
What
  • Karolinska Institutet study analyzed 7,308 patients with atrial fibrillation and Alzheimer’s.
  • Participants were grouped to NOACs, warfarin, or no anticoagulant treatment.
  • NOACs slowed MMSE decline by about 0.2 points per year versus others.
  • NOACs also linked to lower risks of death, stroke, clots, and fractures.
  • Study notes observational design and cannot prove causation; potential confounders exist.
Where
🇺🇸 United States (outlet HQ)
topics: Health, Science, Education · language: eng
When
published 18 Sept, 09:48Z
ingested 18 Sept, 10:51Z
Rewrite
original kept above, struck through · model ?
Retrieved
https://www.sciencedaily.com/releases/2026/09/260917003732.htm
Read the original ↗ Back to the story Data (JSON)
Everything above is the full audit trail for this article: source, country, timestamps, the original headline, and the model that rewrote it. Nothing is hidden.